| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2144115 | Lung Cancer | 2006 | 7 Pages |
Abstract
Patients with poor performance status treated with platinum based chemotherapy have a similar rate of toxicity compared to good performance status patients. Their overall survival was lower despite a similar response to chemotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Thomas E. Stinchcombe, Jaeun Choi, Michael J. Schell, Andrea Mears, Paul E. Jones, Robert V. Nachtsheim, Mark A. Socinski,
